Stroke Incidence and Survival in the Beginning of the 21st Century in Southern Sweden: Comparisons with the Late 20th Century and Projections into the Future
Overview
Neurology
Affiliations
Background And Purpose: We report trends of stroke incidence and survival up to year 2001/2002 in Lund-Orup, Sweden, and projections of future stroke incidence in Sweden.
Methods: Lund Stroke Register, a prospective population-based study, included all first-ever stroke patients, between March 1, 2001 and February 28, 2002, in the Lund-Orup health care district. Institution-based studies for 1983 to 1985 and 1993 to 1995 were used for comparison. We calculated age-standardized incidence and Cox proportional hazards analysis of survival (stroke subtype, sex, age group, and study period in the analysis). Minimum follow-up was 46 months. Based on our register's stroke incidence and the official Swedish population projection, a projection for future stroke incidence on a national basis was calculated.
Results: We included 456 patients with first-ever stroke in 2001/2002. The age-standardized incidence (to the European population) was 144 per 100 000 person-years (95%CI 130 to 158) in 2001/2002, 158 (95%CI 149 to 168) in 1993 to 1995, and 134 (95%CI 126 to 143) in 1983 to 1985. Cox proportional hazard analysis indicated decreased risk of death after stroke in 2001/2002 (hazard ratio 0.80; 95%CI 0.67 to 0.94) compared with 1993 to 1995. Up to year 2050, the annual number of new stroke patients in Sweden may increase by 59% based solely on demographic changes.
Conclusions: Despite possible underestimation of stroke incidence during the previous institution-based studies, the increased stroke incidence between 1983 to 1985 and 1993 to 1995 did not continue in 2001/2002. The long-term survival after stroke continues to improve. As the elderly population is growing in Sweden, stable incidence and increasing survival will result in a rapidly increasing prevalence of stroke patients in Sweden.
Chen L, Li J, Wang S, Zhao L, Hu S Thromb J. 2024; 22(1):111.
PMID: 39696513 PMC: 11657298. DOI: 10.1186/s12959-024-00671-y.
Wafa H, Marshall I, Wolfe C, Xie W, Johnson C, Veltkamp R Lancet Reg Health Eur. 2024; 38:100842.
PMID: 38362494 PMC: 10867656. DOI: 10.1016/j.lanepe.2024.100842.
Duloquin G, Bejot Y Front Public Health. 2023; 11:1142134.
PMID: 37304110 PMC: 10248396. DOI: 10.3389/fpubh.2023.1142134.
The costs associated with stroke care continuum: a systematic review.
Lucas-Noll J, Clua-Espuny J, Lleixa-Fortuno M, Gavalda-Espelta E, Queralt-Tomas L, Panisello-Tafalla A Health Econ Rev. 2023; 13(1):32.
PMID: 37193926 PMC: 10190015. DOI: 10.1186/s13561-023-00439-6.
A Genomic Risk Score Identifies Individuals at High Risk for Intracerebral Hemorrhage.
Myserlis E, Georgakis M, Demel S, Sekar P, Chung J, Malik R Stroke. 2023; 54(4):973-982.
PMID: 36799223 PMC: 10050100. DOI: 10.1161/STROKEAHA.122.041701.